A study by Warner et al. [24] proposed four biomarkers overall associated with BC (adiponectin, C-peptide, high sensitivity C-reactive protein, and insulin-like growth factor-1) that seem related to ACEs with an increased risk of developing estrogen-receptor (ER) and, therefore, BC. Here, ADIPOQ is linked to breast cancer.